RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
0.8500
-0.0393 (-4.42%)
At close: Apr 10, 2025, 4:00 PM
0.8365
-0.0135 (-1.59%)
After-hours: Apr 10, 2025, 7:51 PM EDT

RAPT Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
1122138556721,085485
Upgrade
Market Cap Growth
-75.05%-75.05%27.19%-38.08%123.77%-19.54%
Upgrade
Enterprise Value
-114120677484874362
Upgrade
Last Close Price
0.851.5824.8519.8036.7319.75
Upgrade
PS Ratio
--440.09284.6196.19
Upgrade
PB Ratio
0.591.125.812.745.824.66
Upgrade
P/TBV Ratio
0.591.125.812.745.824.66
Upgrade
EV/Sales Ratio
--317.25229.3371.83
Upgrade
Debt / Equity Ratio
0.020.020.050.04--
Upgrade
Asset Turnover
---0.010.020.05
Upgrade
Quick Ratio
4.784.787.2817.5119.779.50
Upgrade
Current Ratio
4.874.877.4117.7720.119.85
Upgrade
Return on Equity (ROE)
-77.09%-77.09%-59.56%-38.86%-47.63%-59.66%
Upgrade
Return on Assets (ROA)
-41.13%-41.13%-36.13%-23.07%-27.24%-32.67%
Upgrade
Return on Capital (ROIC)
-48.84%-48.84%-38.92%-24.34%-29.77%-37.52%
Upgrade
Earnings Yield
-115.74%-60.90%-13.66%-12.48%-6.38%-10.91%
Upgrade
FCF Yield
-74.34%-39.12%-11.49%-10.66%-5.69%-8.43%
Upgrade
Buyback Yield / Dilution
-6.32%-6.32%-17.82%-18.80%-13.49%-455.27%
Upgrade
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q